IV 
114TH CONGRESS 
1ST SESSION 
H. RES. 174 
Expressing support for designation of March as ‘‘National Multiple Myeloma 
Awareness Month’’. 
IN THE HOUSE OF REPRESENTATIVES 
MARCH 25, 2015 
Mr. HIGGINS (for himself, Ms. NORTON, and Mr. HASTINGS) submitted the 
following resolution; which was referred to the Committee on Oversight 
and Government Reform 
RESOLUTION 
Expressing support for designation of March as ‘‘National 
Multiple Myeloma Awareness Month’’. 
Whereas multiple myeloma (or myeloma) is a cancer of plas-
ma cells in the bone marrow and is called ‘‘multiple’’ be-
cause it can occur at various sites in the body; 
Whereas multiple myeloma causes a variety of adverse health 
effects, including a weakened immune system, anemia, 
kidney damage, and bone deterioration; 
Whereas multiple myeloma is the second most common blood 
cancer worldwide; 
Whereas multiple myeloma currently affects more than 
100,000 people in the United States, with about 22,350 
new cases diagnosed and 10,710 deaths from the disease 
VerDate Sep 11 2014 
00:46 Mar 26, 2015
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR174.IH
HR174
emcdonald on DSK67QTVN1PROD with BILLS
•HRES 174 IH 
in 2013 according to the National Cancer Institute’s Sur-
veillance, Epidemiology, and End Results Program; 
Whereas once predominately found among those 65 and over, 
where it continues to be most frequently diagnosed, mul-
tiple myeloma is increasingly being identified in younger 
age individuals including those in their 30s, 40s, and 50s; 
Whereas multiple myeloma is almost twice as likely to occur 
among African-Americans and is one of the leading 
causes of cancer deaths among African-Americans, with 
scientific understanding of the disparity remaining un-
known; 
Whereas the cause of multiple myeloma is not known, with 
robust research being performed in the United States and 
internationally into potential genetic, environmental, and 
other risk factors; 
Whereas recent years have seen the development of new 
drugs 
and 
treatments 
that 
have 
improved 
life 
expectancies and significantly enhanced the quality of life 
for patients; 
Whereas additional new drugs and therapies are in the re-
search phase, with patient enrollment in clinical trials 
playing an important role in determining safe and effec-
tive treatments; 
Whereas understanding and treatment of multiple myeloma 
has been greatly furthered by the role of advocacy initia-
tives promoting awareness, education, research, peer re-
view, and collaboration and such efforts are to be highly 
commended; 
Whereas greater awareness of multiple myeloma on the part 
of clinicians and the general public can lead to earlier de-
VerDate Sep 11 2014 
00:46 Mar 26, 2015
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR174.IH
HR174
emcdonald on DSK67QTVN1PROD with BILLS
•HRES 174 IH 
tection and treatment, improving health outcomes and 
bringing comfort to patients and their families; and 
Whereas March would be an appropriate month to designate 
as ‘‘National Multiple Myeloma Awareness Month’’: Now, 
therefore, be it 
Resolved, That the House of Representatives supports 
the designation of ‘‘National Multiple Myeloma Awareness 
Month’’ to increase public knowledge of this disease and 
advance the vision of finding a cure for multiple myeloma. 
Æ 
VerDate Sep 11 2014 
00:46 Mar 26, 2015
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\HR174.IH
HR174
emcdonald on DSK67QTVN1PROD with BILLS